---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-140267"
form_type: "8-K"
ticker: "PSTV"
cik: "0001095981"
company_name: "PLUS THERAPEUTICS, INC."
filed_at: "2026-04-02T23:59:59+00:00"
generated_at: "2026-05-15T07:47:21.798821+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Plus Therapeutics approves 1-for-25 reverse stock split to meet Nasdaq $1.00 minimum bid price

## Summary
- Reverse split at 1-for-25, effective 12:01 a.m. ET on April 2, 2026; shares drop from ~171.6M to ~6.86M.
- Action taken to increase per-share price above Nasdaq's $1.00 minimum bid requirement for continued listing.
- No fractional shares issued; cash in lieu; new CUSIP 72941H806; trading symbol stays PSTV.
- Broadridge acts as exchange agent; book-entry holders need no action; certificates receive instructions.
- Par value unchanged at $0.001; proportional adjustments to equity awards and warrants.

## SEC filing metadata
- accession: 0001193125-26-140267
- form_type: 8-K
- ticker: PSTV
- cik: 0001095981
- company_name: PLUS THERAPEUTICS, INC.
- filed_at: 2026-04-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- confidence: high
- sec_items: 3.03, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1095981/000119312526140267/0001193125-26-140267-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1095981/000119312526140267/pstv-20260401.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-140267
- JSON: https://secwatch.observer/filing/0001193125-26-140267.json
- Plain text: https://secwatch.observer/filing/0001193125-26-140267.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.